Concepts (58)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Melanosis | 1 | 2021 | 10 | 0.730 |
Why?
|
| Neurocutaneous Syndromes | 1 | 2021 | 17 | 0.720 |
Why?
|
| GTP Phosphohydrolases | 1 | 2021 | 144 | 0.680 |
Why?
|
| Pseudoxanthoma Elasticum | 1 | 2018 | 1 | 0.630 |
Why?
|
| Meningeal Neoplasms | 1 | 2021 | 185 | 0.630 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2018 | 20 | 0.620 |
Why?
|
| Skin Diseases, Vesiculobullous | 1 | 2017 | 2 | 0.580 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2017 | 14 | 0.570 |
Why?
|
| Drug Eruptions | 1 | 2017 | 32 | 0.550 |
Why?
|
| Ceftriaxone | 1 | 2017 | 68 | 0.550 |
Why?
|
| Immunocompetence | 1 | 2017 | 33 | 0.550 |
Why?
|
| Necrobiosis Lipoidica | 1 | 2016 | 2 | 0.540 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2017 | 73 | 0.530 |
Why?
|
| Sarcoma, Kaposi | 1 | 2017 | 120 | 0.490 |
Why?
|
| Anemia, Sickle Cell | 1 | 2018 | 339 | 0.470 |
Why?
|
| Melanoma | 1 | 2021 | 834 | 0.440 |
Why?
|
| Membrane Proteins | 1 | 2021 | 1528 | 0.420 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 804 | 0.330 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2016 | 826 | 0.300 |
Why?
|
| Skin | 2 | 2018 | 512 | 0.240 |
Why?
|
| Tuberculosis, Lymph Node | 1 | 2020 | 21 | 0.180 |
Why?
|
| Neck | 1 | 2020 | 137 | 0.160 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2017 | 39 | 0.140 |
Why?
|
| Back | 1 | 2017 | 11 | 0.140 |
Why?
|
| Nursing Homes | 1 | 2018 | 95 | 0.140 |
Why?
|
| Cultural Competency | 1 | 2018 | 51 | 0.140 |
Why?
|
| HIV Seronegativity | 1 | 2017 | 27 | 0.140 |
Why?
|
| Clobetasol | 1 | 2016 | 3 | 0.140 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2020 | 378 | 0.130 |
Why?
|
| Foot | 1 | 2017 | 63 | 0.130 |
Why?
|
| Mutation | 2 | 2021 | 5810 | 0.130 |
Why?
|
| Health Promotion | 1 | 2018 | 392 | 0.110 |
Why?
|
| Child | 3 | 2021 | 24454 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 283 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 1238 | 0.110 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 1690 | 0.110 |
Why?
|
| Students, Medical | 1 | 2018 | 356 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 2090 | 0.100 |
Why?
|
| Female | 4 | 2021 | 66534 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1894 | 0.100 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 5153 | 0.090 |
Why?
|
| Prognosis | 1 | 2021 | 4607 | 0.090 |
Why?
|
| Humans | 7 | 2021 | 124778 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 3586 | 0.080 |
Why?
|
| Phenotype | 1 | 2018 | 4261 | 0.080 |
Why?
|
| Infant | 2 | 2021 | 12483 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2021 | 8181 | 0.070 |
Why?
|
| Young Adult | 1 | 2021 | 8982 | 0.070 |
Why?
|
| Male | 3 | 2021 | 61267 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2021 | 14050 | 0.060 |
Why?
|
| Retrospective Studies | 1 | 2021 | 16298 | 0.050 |
Why?
|
| Adolescent | 1 | 2021 | 19327 | 0.050 |
Why?
|
| Adult | 1 | 2021 | 29458 | 0.040 |
Why?
|
| Radiography, Thoracic | 1 | 2020 | 154 | 0.040 |
Why?
|
| Aged | 1 | 2017 | 19679 | 0.040 |
Why?
|
| Middle Aged | 1 | 2017 | 26701 | 0.040 |
Why?
|
| Quality of Life | 1 | 2018 | 1945 | 0.020 |
Why?
|
| United States | 1 | 2018 | 10883 | 0.010 |
Why?
|